Further investigations of complex 2 indicated its potential as an apoptosis-inducing agent in breast cancer MDA-MB-231 cells, with upregulation of caspase-3, downregulation of BCL-xL, and alterations in mitochondrial membrane potential. The gene discussed is CASP3; the disease is breast carcinoma.